BANYU PHARMACEUTICAL ANNOUNCES SUBANALYSIS OF J-LIT, LARGE-SCALE CLINICAL TRIALS OF ANTI-HYPERLIPIDEMIC AGENT LIPOVAS

A A

Banyu Pharmaceutical recently published the results of the Japan Lipid Intervention Trial (J-LIT), large-scale clinical trials of LIPOVAS, its proprietary anti-hyperlipidemic agent, in Circulation Journal, an academic and professional publication of the Japanese Circulation Society.

JCN Network (http://www.japancorp.net/Article.Asp?Art_ID=12768)